Insider Trading History of Manning Martha E

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Manning Martha E since 2008. This trader's CIK number is 1227894. At the time of last reporting, Manning Martha E was the SVP, GEN. COUNSEL & CORP. SEC. of Marinus Pharmaceuticals, Inc.. (stock ticker symbol MRNS). Also see all insider trading activities at Marinus Pharmaceuticals, Inc..

Note that in the past MANNING MARTHA E also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Marinus Pharmaceuticals, Inc. (MRNS) by Manning Martha E

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 MRNS 0 $0 5,515 $22,216 0 $0
2023 MRNS 0 $0 2,180 $20,790 0 $0

Yearly summary of insider trading at Adolor Corp (ADLR) by Manning Martha E

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2008 ADLR 0 $0 0 $0 11,500 $0


Insider trading activities at 2 companies by Manning Martha E:

1. Marinus Pharmaceuticals, Inc. (MRNS)

2. Adolor Corp (ADLR)

Table 1. Insider trading of Marinus Pharmaceuticals, Inc. (MRNS) by Manning Martha E

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-08-05 MRNS Sale 3,621 1.13 4,091
2024-02-20 MRNS Sale 1,894 9.57 18,125
2023-08-08 MRNS Sale 11 8.93 98
2023-08-07 MRNS Sale 2,169 9.54 20,692

Table 2. Insider trading of Adolor Corp (ADLR) by Manning Martha E

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2008-05-20 ADLR Option Ex 11,500 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Manning Martha E (SVP, GEN. COUNSEL & CORP. SEC. of Marinus Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.